Samrat Pharmachem Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

3.09

3.09

3.09

3.09

3.09

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

61.91

60.05

43.73

26.55

21.21

Loan funds

Secured loans

8.45

18.66

7.52

8.79

9.10

Unsecured loans

-

-

-

-

-

Total

73.45

81.80

54.34

38.43

33.40

Uses of funds

Fixed assets

Gross block

16.53

16.17

14.81

13.93

11.36

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

5.81

5.47

4.83

4.52

4.18

Net block

10.72

10.70

9.99

9.40

7.19

Capital work-in-progress

-

-

-

-

1.08

Investments

2.93

1.88

0.01

-

-

Net current assets

Current assets, loans & advances

108.09

103.57

74.62

47.99

50.08

Less : current liabilities & provisions

48.28

34.35

30.27

18.97

24.95

Total net current assets

59.80

69.22

44.35

29.03

25.13

Miscellaneous expenses not written

-

-

-

-

-

Total

73.45

81.80

54.34

38.43

33.40

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

0.01

0.01

0.01

-

-

Contingent liabilities

0.07

0.07

0.07

0.07

0.07

Number of equity sharesoutstanding (Lacs)

30.90

30.90

30.90

30.90

30.90